BRAINFUTURES

Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies, issues related to medical adoption of psychedelic drugs and therapies, issues related to equitable access to psychedelic drugs and therapies; S. 689/H.R. 1393, A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes, all provisions.

Education and advocacy related to treatments for mental health and substance use disorder.